drugset / Trial / NCT02089412

A Study to Determine the Effect of a High-Fat Meal on the Rate and Extent of E2006 Absorption in Healthy Subjects

NCT02089412

Phase 1 Completed 59 enrolled Eisai Inc.
RandomizedSingle-groupOpen-labelTreatment

Summary

This is an open-label, single-dose, randomized crossover study of single oral 10-mg tablet doses administered either after an overnight fast or in combination with a standard high-fat meal in healthy subjects.

Timeline

Start
2014-02
Primary completion
2014-05
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lemborexant Small molecule 10 mg Oral

Indications

No indication recorded.